MLYS
Mineralys Therapeutics, Inc.
Next earnings Aug 10, 2026 · consensus $-0.54 EPS
Last earnings +2.9% on 2026-05-06
$25.78
▲ +0.64%$25.78▲ +87.73%
over 1Y
L $12.87EODHDH $47.33
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.6%
1W+2.6%
1M-14.1%
3M+4.7%
YTD-27.8%
1Y+87.7%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Buy
Mixed signals in the latest filings.
Mineralys Therapeutics, Inc. shows limited reported revenue, and -23.9% ROE.
Sources: SEC EDGAR (CIK 0001933414, latest 10-Q filed 2026-05-06) · EODHD · as of 6/25/2026, 8:54:28 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.